美好医疗
(301363)
| 流通市值：33.38亿 | | | 总市值：121.02亿 |
| 流通股本：1.12亿 | | | 总股本：4.07亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,156,571,221.99 | 706,449,459.94 | 281,550,999.26 | 1,337,586,673.34 |
| 营业收入 | 1,156,571,221.99 | 706,449,459.94 | 281,550,999.26 | 1,337,586,673.34 |
| 二、营业总成本 | 878,898,846.47 | 514,255,774.5 | 216,931,034.93 | 996,545,047.34 |
| 营业成本 | 673,298,597.6 | 416,585,011.8 | 173,752,349.63 | 786,627,427.32 |
| 税金及附加 | 10,661,892.44 | 6,238,196.45 | 952,826.18 | 8,586,210.29 |
| 销售费用 | 30,315,989.59 | 15,941,959.55 | 9,203,418.54 | 31,832,560.21 |
| 管理费用 | 74,753,349.52 | 43,160,815.94 | 23,358,728.66 | 101,291,281.58 |
| 研发费用 | 103,341,218.61 | 57,386,444.88 | 22,716,655.12 | 120,403,232.88 |
| 财务费用 | -13,472,201.29 | -25,056,654.12 | -13,052,943.2 | -52,195,664.94 |
| 其中:利息费用 | - | - | - | 332,175 |
| 其中:利息收入 | 30,727,362.44 | 19,425,840.98 | 10,579,786.04 | 34,740,822.56 |
| 加:公允价值变动收益 | 304,900.26 | 433,913.74 | 121,668.33 | 83,754.64 |
| 加:投资收益 | 6,526,682.47 | 4,803,118.37 | 527,840.49 | 15,661,273.67 |
| 资产处置收益 | -280,245.31 | -323,527.84 | -322,003.82 | -85,028.82 |
| 资产减值损失(新) | -2,782,594.76 | -797,022.35 | - | -7,437,617.82 |
| 信用减值损失(新) | -1,802,546.35 | -4,336,081.26 | -419,558.6 | -12,266,409.33 |
| 其他收益 | 9,682,528.7 | 4,437,689.18 | 3,613,507.42 | 14,713,154.04 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 289,321,100.53 | 196,411,775.28 | 68,141,418.15 | 351,710,752.38 |
| 加:营业外收入 | 4,265.56 | 2,905.13 | 3,111.85 | 22,261.13 |
| 减:营业外支出 | 99,501.41 | 94,553.17 | 87,121.88 | 316,455.47 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 289,225,864.68 | 196,320,127.24 | 68,057,408.12 | 351,416,558.04 |
| 减:所得税费用 | 31,376,652.86 | 27,144,782.11 | 10,017,537.92 | 38,115,982.99 |
| 六、净利润 | 257,849,211.82 | 169,175,345.13 | 58,039,870.2 | 313,300,575.05 |
| 持续经营净利润 | 257,849,211.82 | 169,175,345.13 | 58,039,870.2 | 313,300,575.05 |
| 归属于母公司股东的净利润 | 257,849,211.82 | 169,175,345.13 | 58,039,870.2 | 313,300,575.05 |
| (一)基本每股收益 | 0.64 | 0.42 | 0.14 | 0.77 |
| (二)稀释每股收益 | 0.64 | 0.42 | 0.14 | 0.77 |
| 八、其他综合收益 | 38,949,424.1 | -6,280,786.77 | -11,377,329.8 | -10,062,819.73 |
| 归属于母公司股东的其他综合收益 | 38,949,424.1 | -6,280,786.77 | -11,377,329.8 | -10,062,819.73 |
| 九、综合收益总额 | 296,798,635.92 | 162,894,558.36 | 46,662,540.4 | 303,237,755.32 |
| 归属于母公司股东的综合收益总额 | 296,798,635.92 | 162,894,558.36 | 46,662,540.4 | 303,237,755.32 |
| 公告日期 | 2024-10-25 | 2024-08-20 | 2024-04-18 | 2024-04-18 |
| 审计意见(境内) | | | | 标准无保留意见 |